FDA·Medicines·December 24, 2025

Taro recalls Ciclopirox 1% shampoo over failed impurity and breakdown tests

Testing at the 18-month point found the shampoo had results outside the allowed limits for impurities and product breakdown, so it did not meet quality standards.

What to do

The notice does not give instructions. Read the official notice for details.

Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.

Recall details

Product
Ciclopirox Shampoo, 1%, 120 mL, Rx only, Mfg by: Taro Pharmaceuticals Inc., Ontario, Canada; Dist. by: Taro Pharmaceuticals USA, Inc., NY 10532. NDC 51672-1351-08
Hazard
Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint
Units
17,664 units
Where sold
Nationwide within the United States
FDA classification
Class II · Ongoing
Classified by FDA
December 17, 2025
Recall started
December 9, 2025
FDA enforcement report
December 24, 2025
Identifiers
  • Codes: Lot #: AD37059, AD37060, AD37061, AD37062, AD37065, AD37066, AD37067, AD37068, expires: 1/31/2026.
  • FDA recall number: D-0240-2026

The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.

Official notice

The notice's own wording from FDA.

Product
Ciclopirox Shampoo, 1%, 120 mL, Rx only, Mfg by: Taro Pharmaceuticals Inc., Ontario, Canada; Dist. by: Taro Pharmaceuticals USA, Inc., NY 10532. NDC 51672-1351-08
Reason for recall
Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint
Classification
Class II (Ongoing)
Distribution
Nationwide within the United States
Quantity
17,664 units

Related recalls